A collaboration of Binaytara Foundation and St. Joseph Regional Medical Center

BTF Logo Updates in Hematologic Malignancies
- A multidisciplinary conference


Aug 10, 2013

Lewis-Clark State College, Williams Conference Center, 500 8th Avenue, Lewiston ID


Overview Registration Objectives Program Faculty Credit Information Contact Exhibition/Sponsorship


Download Brochure (PDF)



Binaytara Foundation
Binaytara Foundation (BTF) is an Illinois non-profit organization exempt from taxation pursuant to Section 501(c)(3) of the Internal Revenue Code. The mission of the foundation is to bring positive change in society by promoting health and education.
Corporate Sponsor:
corporate sponsor

Updates in Hematologic Malignancies – A multidisciplinary conference will have balanced educational sessions focusing on the needs of hematologists, oncologists, primary care physicians, nurses, pharmacists and other healthcare professionals involved in management of hematologic malignancies. Faculty will discuss current and emerging concepts in the field of hematologic malignancies.


Organizing Committee:


1. Dr. Michael Rooney - Conference Chair

2. Dr. Binay Shah

3. Pamela Sly, RN

4. Pamela Reed, RN, BSN, OCN

5. Tamara Jones, RN

6. Paul Driver, PharmD


Target Audience:


1. Hematologists

2. Oncologists

3. Primary Care providers (Internists, Family practioners, NP, PA)

4. Nurses

5. Pharmacists

6. Other healthcare professionals involved in management of hematologic malignancies (Social workers, physical therapists, nutritionists)


Needs assessment:


There have been several new developments in the field of hematologic malignancies. Five new drugs - ponatinib, omacetaxine, bosutinib, vinctistine - liposomal injection, carfilzomib were approved in 2012 and pomalidomide was approved in 2013 for treatment of hematologic malignancies. There is a need for educational sessions for healthcare providers involved in management of hematologic malignancies.




Physicians: USD 100 (until June 30, 2013), USD 125 (until August 9th, 2013) USD 150 (onsite)

RN/NP/PA/PharmD/Allied Health Professionals: USD 50 (June 30, 2013), USD 75 (until August 9th, 2013) USD 100 (onsite)

Please pay the registration fees by clicking on the button below. Once the transaction is completed, you will be presented with the registration page. If you would like to pay by check, please complete the Registration Form, write a check to "Binaytara Foundation" and mail to:
Linda Petrie
Department of Education
St. Joseph Regional Medical Center
415 6th Street
Lewiston, ID 83501
office: 208-799-5217


Registration Fee
Your Full Name

For other payments, click here!


Educational Objectives:


At the conclusion of this activity, participants will be able to


a) recognize factors that affect the diagnosis, staging, and prognosis of patients with hematologic malignancies

b) explain indications and contraindications of treatments used for hematologic malignancies

c) discuss emerging therapeutic options for treating patients with hematologic malignancies with colleagues and patients

d) interpret new, practice relevant data presented at ASCO 2013

e) nurses will be able to provide appropriate care and counsel patients with hematologic malignancies and their families


Educational Program:


August 10, 2013

7 am

Registration, breakfast

7:45 am


8 am

Case based discussion on multiple myeloma – Dr. Edward Libby

8:30 am

Case based discussion on low grade lymphoma – Dr. Binay Shah

9:00 am

Case based discussion on high grade lymphoma – Dr. Edward Libby

9:30 am

Q & A Session

10:00 am


10:30 am

Case based discussion on chronic myeloid leukemia – Dr. Divyesh Mehta

11:00 am

Case based discussion on myeloproliferative disorders – Dr. Damiano Rondelli

11:30 am

Challanges in managing patients with hematologic malignancies - Nurses perspective – Dr. Sandra Cuellar

12:00 pm

Q & A Sessions

12:30 pm





1. Professor Damiano Rondelli, Chief of Hematology/Oncology, University of Illinois, Chicago

2. Professor Divyesh Mehta, Chief of Hematology/Oncology, Division at Maricopa Integrated Health System, Phoenix, AZ

3. Dr. Binay K Shah, Hematologist/Oncologist, St. Joseph Regional Medical Center

4. Dr. Edward Libby, Seattle Cancer Care Alliance

5. Sandra Cueller, PharmD, Assistant Professor, University of Illinois, Chicago


Faculty Bios:


edwardDr. Edward Libby received his B.S. in Chemistry from theUniversity of Texas at El Paso and his M.D. from the University of Texas Health Science Center atHouston. He completed his Internal Medicine residency at the University of New Mexico(UNM) in Albuquerque and then completed training inHematology at UNM as well. At the University of New Mexico Dr Libby led the Hematologic Malignancies group and managed the stem cell transplant team from its inception. He then joined the Seattle Cancer Care Alliance to advance his research career and to focus exclusively in myeloma and lymphoma.


sandraSandra Cuellar, Pharm.D., BCOP, is a Clinical Assistant Professor in the Department of Pharmacy Practice at the University of Illinois at Chicago (UIC) College of Pharmacy. Dr. Cuellar has been active in the field of hematology/oncology for 10 years. She is the coordinator and clinical assistant professor for oncology therapeutics. Dr. Cuellar received her Bachelor of Liberal Arts from Augustana College in Rock Island, Illinois, followed by her Pharm.D. degree from the University of Illinois at Chicago College of Pharmacy. She then completed a Pharmacy Practice Residency at University of Kentucky Chandler Medical Center. Following her residency, she completed a specialty oncology residency at MD Anderson Cancer Center in Houston, Texas. She currently is the clinical pharmacist in the Out-Patient Cancer Center and is also the director of the oncology specialty residency program at UIC. Dr. Cuellar is an editor at large for Journal of Hematology Oncology Pharmacy and is involved in research, consulting and publications in the field of hematology/oncology.


binayDr. Binay Shah is a hematologist and oncologist at St. Joseph Regional Medical Center, Lewiston, Idaho. His clinical research focusses on health services and outcomes. Dr. Shah has published a number of papers in peer-reviewed journals including Journal of Clinical Oncology, British Journal of Hematology, Leukemia and Lymphoma, Acta Hematologica, Annals of Hematology. He has presented a number of research papers in national and international conferences. He is a reviewer of many esteemed journals including Annals of Internal Medicine, European Journal of Hematology, Platelets etc.
Dr. Shah is the Founder President of Binaytara Foundation. He serves as a board member of Idaho Society of Clinical Oncology.
Dr. Shah received his medical degree from BP Koirala Institute of health Sciences, Dharan, Nepal. He completed Internal Medicine residency from Long Island College Hospital, Brooklyn and Hematology Oncology fellowship from University of Illinois at Chicago.


divyeshDivyesh G. Mehta, MD is Professor Of Medicine at University Of Arizona College Of Medicine and Chief of Hematology Oncology Division at Maricopa Integrated Health System, Phoenix, AZ. Dr. Mehta is a Professor of Medicine at University of Arizona College of Medicine. Dr. Mehta has research interest in Triple Negative Breast Cancer and Multi modality treatment of Hepatocellular Carcinoma.
Dr Mehta received his MD from Medical College in Baroda, India. Subsequently, he completed two internships, one at SSG Hospital in Baroda and one at St. Mary of Nazareth Hospital in Chicago. These were followed by an internal medicine residency at Louis A. Weiss Memorial Hospital in Chicago and a hematology/oncology fellowship at the University of Illinois.
He pioneered several efforts in India including setting up Western India’s first comprehensive component blood bank at Children’s Hospital in Baroda and helping to found the Indian Cooperative Oncology Network, which focuses on cancer research. Dr Mehta has authored 3 book chapters; the most recent is titled “Platelet Disorders” for the 2003 edition of the API Textbook of Medicine.


damianoDr. Damiano Rondelli is a Professor of Medicine and Director of Stem Cell Transplant Program at the University of Illinois at Chicago.
His clinical research focuses on allogeneic stem cell transplantation. In particular, his interest has been on the use of i.v. busulfan in transplant conditioning regimens, stem cell transplantation in myelofibrosis and identification of biomarkers of acute and chronic GVHD by flow cytometry. His laboratory focuses on in-vitro and in-vivo models of T cell alloreactivity against hematopoietic stem cells and translational strategies to overcome it.
Dr. Rondelli serves as a member of the International Myeloproliferative Disorders Research Consortium (MPD-RC), funded by an NCI PO1 grant (PI Ronald Hoffman, MD) where he chairs a study using a reduced intensity conditioning regimen in allogeneic stem cell transplantation for patients with myelofibrosis.
Dr. Rondelli has published over 90 full-papers in international peer-reviewed journals including Blood, Leukemia, Biology Blood Marrow Transplantation, and is a co-author of an Italian Hematology textbook. “Lezioni di Ematologia” by Sante Tura et al, Esculapio Bologna, 2003. He is a reviewer of many esteemed journals including Blood, Cancer research, American Journal of Transplantation, etc.
Dr. Rondelli received his medical degree with honors from the University of Bologna, Italy. After completing School of specialization in hematology at the University of Bologna, he worked as research associate at the Fred Hutchinson Cancer Research Center, Seattle, WA where he started his studies on the antigen presenting function of CD34+ hematopoetic stem cells.


Credit Information:


This activity has been planned and implemented in accordance with the Essential Elements, Criteria, and Standards of Accreditation of the Idaho State Medical Association CME Accreditation Committee through the partnership of Gritman Medical Center and St Joseph Regional Hospital. Gritman Medical Center is an Idaho State Medical Association accredited sponsor, and designates this educational activity for a maximum of 3.5 hours of AMA PRA Category Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Exhibitors' Information:


Please find a letter of invitation and registration form here
Download Exhibitor's Form
Sponsorship Guide

We would like to thank the support of the following partners/sponsors/exhibitors:

Platinum Sponsor


Educational Grant









Lynda Irish, M.Ed.
Director of Education
St. Joseph Regional Medical Center
415 6th Street
Lewiston, ID 83501
office: 208-799-5217